Clinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its ban
- 15 March 2004
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 218 (1-2) , 85-90
- https://doi.org/10.1016/j.jns.2003.11.007
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- ‘…and C is for Clioquinol’ – the AβCs of Alzheimer's diseaseTrends in Neurosciences, 2002
- Treatment of Alzheimer’s Disease with ClioquinolDementia and Geriatric Cognitive Disorders, 2001
- Clioquinol's Return: Cautions from JapanScience, 2001
- Changes in uptake of vitamin B12 and trace metals in brains of mice treated with clioquinolJournal of the Neurological Sciences, 2000
- Clioquinol-Zinc Chelate: A Candidate Causative Agent of Subacute Myelo-Optic NeuropathyMolecular Medicine, 1998
- SMON and Pharmacokinetics of Chinoform with Special Reference to Animal Species DifferenceYAKUGAKU ZASSHI, 1997
- SUBACUTE MYELO-OPTICO-NEUROPATHY (S.M.O.N.) IN JAPAN: A Community SurveyThe Lancet, 1971
- NEUROLOGICAL SYNDROME ASSOCIATED WITH CLIOQUINOLThe Lancet, 1971
- Myeloneuropathy with abdominal disorders in JapanNeurology, 1971